CFO
ARWR icon

CVA Family Office’s Arrowhead Research ARWR Stock Holding History

CVA Family Office’s Portfolio ARWR Stock Details ARWR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-24
Closed -$451 – 1398
2024
Q4 		$451 Buy
+24
New +$494 ﹤0.01% 1257

Other funds holding ARWR

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SPC
Slate Path Capital New York $6.73B AUM 95.97% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

CVA Family Office's ARWR Position: Q1 2025 in Review

CVA Family Office sold out of Arrowhead Research (ARWR) in Q1 2025, closing a stake of 24 shares — an estimated $451 sold.

CVA Family Office first reported a position in ARWR in Q4 2024 and held it in 1 quarter. The position peaked at $451 in Q4 2024. 265 funds tracked by Wall St. Rank hold ARWR as of Q1 2025.

  • CVA Family Office reported no remaining Arrowhead Research position as of Q1 2025 after selling out during the quarter.
  • CVA Family Office sold 24 Arrowhead Research shares in Q1 2025, an estimated $451.
  • CVA Family Office first reported a position in Arrowhead Research in Q4 2024 and held it in 1 quarter.
  • CVA Family Office's Arrowhead Research position peaked at $451 in Q4 2024.
  • 265 funds tracked by Wall St. Rank held Arrowhead Research as of Q1 2025.

Based on CVA Family Office's 13F filing for Q1 2025, filed 16 Apr 2025.